Colorado has served as the perfect launching pad for a number of successful ventures under the Quandary banner. With two years of zero turnover, a portfolio of disruptive technologies developed and eight-digit revenues for our ventures in the books, we're just getting warmed up.
I am fortunate to have had the opportunity to serve the Colorado startup community as a patent attorney for the past three years. My patent firm, Rocky Mountain Patent, has worked with hundreds of Colorado startups to provide the foundational intellectual property protections needed for success. The firm now features more than 10 Ph.Ds, engineers and lawyers continuing to serve the startup community. Our patent team, in addition to providing excellent service for our clients, has provided a critical launching pad for a number of additional ventures under the Quandary name.
In late 2014, I founded a medical device company called Quandary Medical on the strength of two spinal device patents that I prepped and filed. Soon after that, I had the opportunity to leverage Quandary Medical to purchase another company, TranS1, which had one of the most important intellectual property portfolios in the spine market. Not too long ago, the company exceeded the $10M revenue threshold. During that time, drawing on the expertise of Rocky Mountain Patent and the Quandary Group, we have advanced many new groundbreaking technologies and filed over 50 patent applications.
Our success has been noticed. The companies have been featured in a number of national publications. Locally, TranS1 has been awarded and recognized in the Denver Post, ColoradoBiz, the Denver Business Journal and in other publications. Our leadership team has individually been nominated for and won a number of awards, including "Top 25 Young Professionals in Colorado," "SuperLawyers," "Denver Trailblazer," and others. You can review some of our national exposure here: https://www.trans1.com/press-media/
Last year, we introduced 3 new product lines, and this year, we anticipate bringing another 5 novel, truly disruptive (but not invasive!) medical device technologies to market. We have built strong relationships with the top spinal surgeons in the world, and let them dictate their needs for us to solve. We listen to our customers. I have set the goal for three digit growth through the end of 2018, and the prospects are good.
Our success is tied to Colorado. We don't have a board of directors, venture capitalists or complicated investor pool telling us what to do or how to do it. We simply have a great Colorado-bred team that listens to our customers. The incredible pool of engineering, legal, marketing and sales talent that we have drawn from in Colorado has enabled us to build an international success story. I wouldn't trade Colorado for anywhere.
With this success, and in conjunction with the Quandary Group, I'm ready to take the next step to advance innovation in Colorado. Stay tuned for an announcement regarding a very special venture fund to further catalyze innovation in Colorado and beyond.
